51成人动漫

OB/Gyn >

Breast Cancer

News, opinions and meeting coverage in obstetrics and gynecology.

RT Add-On Boosts Outcomes in 'Low-Risk' DCIS Breast Ca

Highest benefit seen in patients who also used tamoxifen

Immunotherapy Wins in Triple-Negative Breast Cancer

Atezolizumab-chemo combo extends PFS, OS in metastatic disease

Nerve Plane Block May Improve Mastectomy Pain

Also: obese children and post-surgery pain; patient-controlled epidurals after C-section

Mastectomy Not the Only Option in Extensive DCIS

Lumpectomy plus RT viable if risks, benefits are explained

Cardiac Imaging in Breast Ca Driven by Therapy

Mismatch between patient risk, imaging decisions

Flap vs Implant for Breast Reconstruction: How to Choose

Experts say decision should be personalized

PI3K Inhibitor Has Mixed Results in Advanced Breast Cancer

Modest progression benefit, but substantial side effects, with taselisib

Exercise Cuts Hyperglycemia For Cancer Patients on Chemo

Pilot study hints at other benefits from walking program

CBT Tops Acupuncture for Treating Insomnia in Cancer Survivors

But both methods provide alternative to sleeping pills

Six Months of Trastuzumab Equal to 12 in Breast Ca

Similar outcomes and less cardiotoxicity, but more research needed

BIS Add-On Reduced Lymphedema in Breast Ca Patients

Bioimpedance spectroscopy plus conservative therapy improved outcomes

Genetic Test Criteria Often Miss Breast Cancer Risk

Similar cancer-linked mutations in patients who did or did not met test criteria

How a Pacemaker Made Cancer Doc a Better Clinician

The wit and wisdom of Larry Norton

Morning Break: Breast Cancer-Schizophrenia Link; FDA on Essure; Rx for Hearing Loss?

Health news and commentary from around the Web gathered by the 51成人动漫 staff

Telemedicine OK for Genetic Testing and Counseling

Trial finds no major difference in psychosocial outcomes

Pearls from: Fatima Cardoso, MD: Part 1

From clinical inertia to future hope for advanced breast cancer

Another CDK4/6 Inhibitor Boosts PFS in Breast Cancer

Abemaciclib-fulvestrant combo for advanced HR+/HER2- disease

Two Anti-HER2 Drugs Slightly Better Than One

Patient selection key to addition of pertuzumab to trastuzumab

Genomic Testing Helps Cancer Patients -- When Results are Used

Also, liquid biopsy can ID drug-responsive tumors

Advanced Ca Patients Benefit from Online Symptom Reports

Patient-reported outcomes tied to increased survival

Trastuzumab Copycat Has Similar Efficacy

Phase III trial compared substances in early-stage breast cancer

Big Win for PARP Inhibitor in Breast Cancer

PFS boost for HER2-negative, BRCA-mutated disease

Novel Agent Shows Antitumor Activity in TRK-Fusion Cancers

Tumor genetics define treatment approach in early-stage trials

Psychosocial Interventions Help Cancer Patients Cope

Programs focus on lowering fear of recurrence, managing advanced disease

Wise Buy? Proton Beam Therapy

It helps only a few, and at a wildly extravagant cost

NCCN Guideline: No Ink on Tumor Suffices in Breast Cancer Tx

New NCCN guidelines discourage centimeter-wide margins

CDK 4/6 Inhibitor Makes the Cut in NCCN Breast Ca Guidelines

Ibrance plus AI or ER antagonist generates 'enthusiasm'

MSK Cancer Alliance: Mainly About Medicine

Bi-directional relationship strengthens regional cancer care

ECC Roundup: Breast Conservation Benefit Varies by Age

And other reports from the European Cancer Congress

3D Mammo Ups Cancer Detection in Women Under Age 50

But tomosynthesis is not without its hassles, expert warns

ESC: Beta-Blocker Cuts Early Heart Damage from Cancer Tx?

No clinical difference in small trial, but preclinical measures suggestive

Make the Diagnosis: Leg Lesion Teaser

Case Findings: A 47-year-old woman undergoing chemotherapy for breast cancer noticed several red, flaccid bullae on her leg. She was also experiencing fever, cough, and shortness of breath, which developed quickly, so she went to the ED. What is your diagnosis?

New Trial 'Justifies' FDA Nod for Ibrance

Phase III study had almost identical results as pivotal trial

Widely Used Breast Chemo Regimen Falls Short

Taxane-cyclophosphamide regimens fail against taxane-anthracycline combinations

Study: Minorities Less Likely to Get Ca Risk Management

Less genetic testing, bilateral mastectomy in black BRCA carriers

Longer Letrozole Equals Less BRCA Recurrence

Study suggests that 10 years is better than five

Trastuzumab Biosimilar Shows Similar Effects

Near-copy of Herceptin may improve global access to treatment

Friday Feedback: How Safe Is Vaginal Estrogen for Breast Cancer Survivors?

ACOG endorsed its use, but what do experts think?

ACOG: Vaginal Estrogen Safe for Breast Ca Survivors

No increased risk of cancer recurrence

Slippery Slope: A Targeted Therapy That Misses the Mark?

Afinitor racks up FDA approvals, but where is the evidence?

鈥�

10